This highlights the potential for therapeutic strategies aimed at modulating RAS equilibrium in sepsis, including the administration of exogenous Ang II, rhACE2 or Ang-(1–7), as well as DPP3 inhibition (Table 1). This evidence concerns the gene DPP3 and Sepsis.